“Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations With Treatment Resistance in Clear Cell and Nonclear Cell Tumors”. 2025. Journal of Kidney Cancer 12 (2): 37-45. https://doi.org/10.15586/jkcvhl.v12i2.386.